Cargando…

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy

For estrogen receptor (ER)-negative breast cancer patients, paclitaxel (P), doxorubicin (A) and cyclophosphamide (C) neoadjuvant chemotherapy (NAC) is the standard therapeutic regimen. Pathologic complete response (pCR) and residual disease (RD) are common surrogate measures of chemosensitivity. Aft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanhua, Cai, Hao, Chen, Wannan, Guan, Qingzhou, He, Jun, Guo, Zheng, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109260/ https://www.ncbi.nlm.nih.gov/pubmed/32269999 http://dx.doi.org/10.3389/fmolb.2020.00034

Ejemplares similares

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Fan, Ming, et al.
Publicado: (2021)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
por: Chen, Rui, et al.
Publicado: (2023)

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2022)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

A Bibliometric Analysis of Cyclophosphamide, Methotrexate, and Fluorouracil Breast Cancer Treatments: Implication for the Role of Inflammation in Cognitive Dysfunction
por: Corley, Christa, et al.
Publicado: (2021)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Protein Misfolding and ER Stress in Huntington's Disease
por: Shacham, Talya, et al.
Publicado: (2019)

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin
por: Yang, Emily Y., et al.
Publicado: (2022)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy?
por: Gentile, Debora, et al.
Publicado: (2022)

Predicting clinical response to everolimus in ER+ breast cancers using machine-learning
por: Nath, Aritro, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021)

ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets
por: Duwaerts, Caroline C., et al.
Publicado: (2022)

Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods
por: Li, Zhandong, et al.
Publicado: (2022)

Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes
por: Chen, Lei, et al.
Publicado: (2020)

Transcriptomic signatures for human male infertility
por: Hodžić, Alenka, et al.
Publicado: (2023)

Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study
por: Liu, Yin, et al.
Publicado: (2022)

Structure and Molecular Mechanism of ER Stress Signaling by the Unfolded Protein Response Signal Activator IRE1
por: Adams, Christopher J., et al.
Publicado: (2019)

Cerebral Blood Flow and its Connectivity Deficits in Patients With Lung Cancer After Chemotherapy
por: Zhang, Yujie, et al.
Publicado: (2022)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures
por: Zhang, Congjun, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Integrated Strategies of Diverse Feature Selection Methods Identify Aging-Based Reliable Gene Signatures for Ischemic Cardiomyopathy
por: Song, Huafeng, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma
por: Wang, Yuxuan, et al.
Publicado: (2021)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2022)

Advances for the treatment of lower extremity arterial disease associated with diabetes mellitus
por: Pan, Yang, et al.
Publicado: (2022)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_31fpl3c9qa8sa613mf92sts3ho